Researchers improve diabetes monitoring

October 22, 2013, University of Bath
Scientists from Bath are developing techniques to screen blood for signs of diabetes, or diseases like as Alzheimer's.

A new way of monitoring blood glucose control in diabetes is a step closer to market thanks to a partnership between researchers from the University and leading medical device company glySure Ltd.

In March scientists from Bath showcased a new technique that could be used in blood tests to screen for diabetes and an array of age-related conditions, including Alzheimer's.

By detecting levels of 'glycated proteins' in blood and , the researchers from the University's Department of Biology & Biochemistry and Department of Chemistry revealed a method to assess damage caused by sugars in age-related diseases.

With the ageing process, proteins in the body react with sugars in what's known as 'glycation'. This damages how certain proteins work and can lead to inflammation or premature ageing.

Through the new technique, developed at Bath, blood samples are put into a thin gel layer and an electric current applied. The gel then acts like a sieve, sorting proteins present according to their size and shape. By using boronic acid labelled with a fluorescent tag, researchers can distinguish between glycated and unmodified proteins, and can also separate glycated proteins from those that have been glycosylated.

Dr Jean van den Elsen explains: "Glycosylation is a normal process in healthy cells where sugars are attached to proteins using enzymes, whereas 'glycation' is damaging for proteins and cells.

"This method allows scientists to identify signature profiles of glycated proteins linked to particular diabetic conditions. In the future the same method could be applied to new technologies to screen for diseases like Alzheimer's."

Professor Tony James added: "We are very excited about working with glySure Ltd on this very exciting project which will take our lab-based research a step closer to helping diagnose and treat people with conditions such as and Alzheimer's disease."

glySure's Barry Crane continued: "glySure Ltd is very happy to be working with the University of Bath on this exciting cost share project. The results of which will help in the design of the next generation of medical sensors for the continuous measurement of glucose in Intensive Care Units."

Explore further: Study explains why diabetic retinopathy is difficult to treat

Related Stories

Study explains why diabetic retinopathy is difficult to treat

October 7, 2013
Damage to the retina due to diabetes can be ameliorated only partially, despite treatment with the standard drug metformin. Scientists of Helmholtz Zentrum München have discovered that metformin treatment normalizes the ...

Grilled, seared foods may add to waistlines, disease risk

December 12, 2012
(Medical Xpress)—A steak slapped onto a hot barbecue will leave the meat with black grill lines that add flavor and aroma, but the chemicals contained in charred, seared and fried foods may over time kick-start the body's ...

New chemical approach to treat Alzheimer's

May 29, 2013
Scientists at the University of Liverpool and Callaghan Innovation in New Zealand have developed a new chemical approach to help harness the natural ability of complex sugars to treat Alzheimer's disease.

Botox proteins could hold cure for diabetes

July 25, 2013
Scientists believe the proteins that are targeted by cosmetic surgery treatment Botox could hold the secret to treating and even curing Type 2 diabetes.

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.